Message Priming and Enrollment in, and Response to, a Smoking Cessation Program: A Pilot Study

Exclusion Criteria

• •1. History of substance abuse and/or currently receiving treatment for substance abuse
• •2. Current alcohol consumption that exceeds \>25 standard drinks/week
• •1. Current use or recent discontinuation (within last 14-days) of the following medications:
• •1. Any form of smoking cessation medication
• •2. Any form of anti-psychotic medications that includes:
• ••antipsychotics,
• ••atypical antipsychotics,
• ••mood-stabilizers,
• ••anti-depressants (tricyclics, SSRI's, MAOI's),
• ••anti-panic agents,
• ••anti-obsessive agents,
• ••anti-anxiety agents, and
• •* stimulants (e.g., Provigil, Ritalin).
• •3. Medication for chronic pain
• •4. Anti-coagulants
• •5. Any heart medications
• •6. Daily medication for asthma
• •1. Women who are pregnant, planning a pregnancy, or lactating.
• •2. History or current diagnosis of psychosis, major depression or bipolar disorder, schizophrenia, or any Axis 1 disorder.
• •3. Serious/unstable disease within the past 6 months (e.g., cancer \[but melanoma\], heart disease, HIV).
• •4. History of epilepsy or a seizure disorder.
• •5. History or current diagnosis (last 6-months) of abnormal rhythms and/or tachycardia (\>100 beats/minute); history or current diagnosis of COPD, cardiovascular disease (stroke, angina, coronary heart disease), heart attack in the last 6 months, uncontrolled hypertension (SBP\>150 or DBP\>90).
• •6. History of kidney and/or liver failure (including transplant).
• •General Exclusion
• •1. Any medical condition or concomitant medication that could compromise participant safety or treatment, as determined by the Principal Investigator and/or Study Physician.
• •2. Inability to provide informed consent or complete any of the study tasks as determined by the Principal Investigator and/or Study Physician.